FDA Inspection 617446 — Maxigen Biotech, Inc.
The FDA completed an inspection of Maxigen Biotech, Inc. on Oct 1, 2009 in Taoyuan City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 1, 2009
- Fiscal Year
- 2010
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Taoyuan City (Taiwan)